Stalevo
Links shared publicly online about this topic
STALEVO IS LINKED TO PROSTATE CANCER
viartis.net — “STALEVO IS LINKED TO PROSTATE CANCER” View full resource at viartis.net
Most Recently Shared on April 2, 2010 at 7:07 am By:
STALEVO IS LINKED TO PROSTATE CANCER http://bit.ly/dhid6x
FDA reviews cardiovascular risks associated with Stalevo - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals that clinical trial data suggesting that Stalevo (carbidopa, levodopa, entacapone, from Novartis) increases the risk for cardiovascular events compared to carbidopa/levodopa (Sinemet, from Bristol-Myers Squibb) is being evaluated.” View full resource at oncologynurseadvisor.com
Most Recently Shared on August 23, 2010 at 2:08 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA reviews cardiovascular risks associated with Stalevo http://goo.gl/fb/dQsmq
FDA evaluating prostate cancer risk with Stalevo - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals and patients that it is evaluating data from the long-term STRIDE-PD clinical trial, that may suggest that patients taking Stalevo (carbidopa/levodopa/entacapone, from Novartis) may be at an increased risk for developing prostate cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 31, 2010 at 8:46 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA evaluating prostate cancer risk with Stalevo http://goo.gl/fb/FiISG
FDA evaluating prostate cancer risk with Stalevo - MPR
empr.com — “The FDA has notified healthcare professionals and patients that it is evaluating data from the long-term STRIDE-PD clinical trial, that may suggest that patients taking Stalevo (carbidopa/levodopa/entacapone, from Novartis) may be at an increased risk for developing prostate cancer.” View full resource at empr.com
Most Recently Shared on March 31, 2010 at 9:07 pm By:
MPR News: FDA evaluating prostate cancer risk with Stalevo: The FDA has notified healthcare professionals and pati... http://bit.ly/aGHNzl
FDA reviews cardiovascular risks associated with Stalevo - MPR
empr.com — “The FDA has notified healthcare professionals that clinical trial data suggesting that Stalevo (carbidopa, levodopa, entacapone, from Novartis) increases the risk for cardiovascular events compared to carbidopa/levodopa (Sinemet, from Bristol-Myers Squibb) is being evaluated.” View full resource at empr.com
Most Recently Shared on August 23, 2010 at 2:12 pm By:
MPR News: FDA reviews cardiovascular risks associated with Stalevo: The FDA has notified healthcare professionals ... http://bit.ly/bTzIjD
FDA Alert: Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
drugs.com — “FDA Alert: Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review” View full resource at drugs.com
Most Recently Shared on March 31, 2010 at 11:30 pm By:
FDA Alert - Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review - http://bit.ly/czroqx
USFDA grants Sun Pharma tentative approval for generic Stalevo ANDA
news-medical.net — “Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Orion's Stalevo® tablets.” View full resource at news-medical.net
Most Recently Shared on October 1, 2010 at 9:10 pm By:
Parkinson's Disease: USFDA grants Sun Pharma tentative approval for generic Stalevo ANDA: Sun Pharmaceutical Indus... http://bit.ly/9yLRas
National Parkinson Foundation - FDA Safety Announcement Regarding Stalevo and Cardiovascular Events
parkinson.org — “National Parkinson Foundation” View full resource at parkinson.org
Most Recently Shared on August 23, 2010 at 3:54 pm By:
New doctor's blog: FDA Safety Announcement Regarding Stalevo and Cardiovascular Events: http://bit.ly/cb5zLj
FDA Alert: Stalevo(carbidopa/levodopa and entacapone): Ongoing Safety Review: Possible increased cardiovascular risk
drugs.com — “FDA Alert: Stalevo(carbidopa/levodopa and entacapone): Ongoing Safety Review: Possible increased cardiovascular risk” View full resource at drugs.com
Most Recently Shared on August 22, 2010 at 11:37 pm By:
FDA Alert - Ongoing Safety Review: Stalevo (carbidopa/levodopa and entacapone) - http://bit.ly/90MUk2
News: FDA to review heart risks of Parkinson's drug Stalevo http://bit.ly/cJBDpb - #health
reuters.com — “News: FDA to review heart risks of Parkinson's drug Stalevo http://bit.ly/cJBDpb - #health” View full resource at reuters.com
Most Recently Shared on August 20, 2010 at 7:15 pm By:
Hisham Rana, MD Doctor and Physician
News: FDA to review heart risks of Parkinson's drug Stalevo http://bit.ly/cJBDpb - #health
Evidence for the Use of Levodopa--Carbidopa--Entacapone (STALEVO) to Improve Motor Fluctuations in Parkinson--™s Disease | Neurology
touchneurology.com — “Evidence for the Use of Levodopa--Carbidopa--Entacapone (STALEVO) to Improve Motor Fluctuations in Parkinson--™s Disease” View full resource at touchneurology.com
Most Recently Shared on November 12, 2010 at 6:15 pm By:
touchNEURO Health Site and Neurology
Evidence for the Use of Levodopa–Carbidopa–Entacapone (STALEVO) to Improve Motor Fluctuations in Parkinson’s Disease http://ow.ly/363hl
Parkinson's Drug Under FDA Review: Stalevo Suspected of Upping Cardiovascular Risk - QualityPoint Technologies
qualitypointtech.net — “The cardiovascular status of patients taking a combination of carbidopa/levodopa and entacapone should be checked, but they should not discontinue the drug unless advised to do so by their physician. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 21, 2010 at 2:27 pm By:
Parkinson's Drug Under FDA Review: Stalevo Suspected of Upping Cardiovascular Risk: The cardiovascular status of ... http://bit.ly/aVLMM3
Evidence for the Use of Levodopa"Carbidopa"Entacapone (STALEVO) to Improve Motor Fluctuations in Parkinson's Disease | Neurology
touchneurology.com — “Evidence for the Use of Levodopa"Carbidopa"Entacapone (STALEVO) to Improve Motor Fluctuations in Parkinson's Disease” View full resource at touchneurology.com
Most Recently Shared on October 23, 2009 at 2:41 pm By:
touchNEURO Health Site and Neurology
http://ow.ly/waxS Improve Motor Fluctuations in Parkinson’s Disease #neurology
FDA cautions about heart risk with Parkinson's drug Stalevo | Local news, sports, weather, blogs, opinion, crime, obituaries, business, directory, marketplace, education, high school, family, shopping, arts, entertainment, movies, books, cooking, auto, re
wenatcheeworld.com — “LOS ANGELES " The Food and Drug Administration on Friday cautioned that it is investigating the possibility that the combination Parkinson's drug Stalevo may increase the risk of heart attack, stroke and death in elderly patients who are taking it. The agency urged patients not to stop taking the drug, but warned them to let their physicians know if the patients have risk factors for cardiovascular disease. Stalevo, sold by Novartis, is a combination of three drugs: carbidopa, levodopa and entac” View full resource at wenatcheeworld.com
Most Recently Shared on August 23, 2010 at 5:10 pm By:
FDA cautions about heart risk with Parkinsons drug Stalevo: LOS ANGELES The Food and Drug Administration on Frida... http://bit.ly/cJusNT
FDA evaluating cancer link in Parkinson's drug | Reuters
reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at reuters.com
Most Recently Shared on April 1, 2010 at 2:01 am By:
Hisham Rana, MD Doctor and Physician
FDA evaluating prostate cancer link to Parkinson's drug Stalevo (carbidopa, levodopa, entacapone) http://bit.ly/b6CN8A - #health
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Prostate Cancer
You just hit the official Twitter Page of Prostate Cancer Community! We have the info you need when it come to Prostate Cancer. Dive in and get connected!
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Advertisement
